A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 9/20 (2006.01) A61K 31/135 (2006.01) A61K 31/216 (2006.01) A61K 31/439 (2006.01) A61K 31/451 (2006.01) A61K 31/485 (2006.01) A61K 47/48 (2006.01)
Patent
CA 2379987
A solid, oral, controlled release dosage form comprising a therapeutically effective amount of an opioid compound, or a salt thereof, a matrix-forming polymer and an ionic exchange resin.
L'invention porte sur une forme posologique orale, solide, à libération continue comportant: une quantité à effet thérapeutique d'un composé d'opioïde ou de l'un de ses sels, un polymère en constituant la matrice, et une résine échangeuse d'ions.
Fetherstonhaugh & Co.
Roxane Laboratories Inc.
LandOfFree
Opioid sustained-released formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Opioid sustained-released formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Opioid sustained-released formulation will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1452305